科伦药业 - Financials

科伦药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
+Revenue	21.8B	21.5B	19.0B	17.3B	16.5B	17.6B	16.4B	11.4B	8.6B	7.8B	8.0B	6.8B	5.9B	5.1B	4.0B	3.2B	2.6B	2.0B
Revenue Growth %	1.7%	12.7%	10.2%	4.9%	-6.6%	7.9%	43.0%	33.5%	10.3%	-3.2%	17.4%	16.1%	14.3%	27.9%	24.0%	23.8%	29.2%	--
Total Revenue	21.8B	21.5B	19.0B	17.3B	16.5B	17.6B	16.4B	11.4B	8.6B	7.8B	8.0B	6.8B	5.9B	5.1B	4.0B	3.2B	2.6B	2.0B
Cost Of Revenue	10.5B	10.2B	9.0B	7.7B	7.5B	7.0B	6.6B	5.6B	4.9B	4.5B	4.6B	3.7B	3.4B	2.9B	2.4B	2.0B	1.7B	1.3B
+Gross Profit	11.3B	11.2B	10.0B	9.6B	8.9B	10.6B	9.7B	5.9B	3.7B	3.3B	3.4B	3.1B	2.5B	2.2B	1.7B	1.3B	948.0M	731.0M
Gross Margin %	51.7%	52.4%	52.5%	55.7%	54.2%	60.2%	59.6%	51.3%	43.3%	42.0%	42.6%	45.7%	42.7%	42.8%	41.0%	38.7%	36.2%	36.0%
Total Operating Cost	18.1B	18.5B	17.3B	16.4B	15.9B	16.7B	15.3B	11.1B	7.9B	7.2B	7.0B	5.7B	4.8B	4.1B	3.3B	2.7B	2.3B	1.8B
Selling Expenses	3.5B	4.5B	4.7B	5.0B	4.9B	6.5B	6.0B	3.1B	1.3B	1.0B	1.0B	887.0M	697.0M	692.0M	592.0M	501.0M	394.0M	311.0M
Admin Expenses	1.3B	1.1B	929.0M	1.1B	1.0B	951.0M	807.0M	738.0M	1.3B	1.1B	855.0M	695.0M	519.0M	392.0M	263.0M	172.0M	131.0M	122.0M
Rd Expenses	2.2B	1.9B	1.8B	1.7B	1.5B	1.3B	909.0M	712.0M	--	--	--	--	--	--	--	--	--	--
Finance Expenses	66.2M	234.0M	480.0M	506.0M	592.0M	572.0M	632.0M	553.0M	293.0M	461.0M	213.0M	164.0M	92.1M	3.3M	7.8M	46.1M	47.0M	30.7M
+Operating Income	4.4B	3.7B	2.2B	1.3B	1.0B	1.3B	1.4B	1.2B	653.0M	574.0M	1.1B	1.1B	1.1B	1.1B	754.0M	506.0M	353.0M	246.0M
Operating Margin %	20.3%	17.0%	11.5%	7.6%	6.1%	7.2%	8.3%	10.1%	7.6%	7.4%	13.6%	16.8%	19.3%	20.6%	18.7%	15.6%	13.5%	12.1%
Non Operating Income	8.8M	11.9M	7.4M	3.3M	12.6M	6.1M	146.0M	7.1M	94.0M	120.0M	89.5M	162.0M	142.0M	66.0M	41.9M	30.0M	16.5M	11.6M
Non Operating Expenses	150.0M	85.6M	135.0M	146.0M	67.5M	26.7M	169.0M	22.7M	31.0M	12.7M	29.5M	28.3M	8.4M	8.2M	21.2M	13.7M	18.1M	1.9M
Investment Income	345.0M	359.0M	235.0M	215.0M	94.8M	174.0M	147.0M	788.0M	15.7M	28.6M	14.9M	2.0M	1.6M	-7.2M	--	--	--	82,300
Fair Value Change Income	19.9M	14.7M	9.9M	4.8M	421,100	--	--	--	--	--	--	--	--	--	--	--	--	-66,700
Asset Disposal Income	807,500	2.6M	5.4M	-7.9M	-20.0M	-4.8M	-11.1M	-21.3M	-14.7M	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	131.0M	131.0M	44.1M	50.4M	57.5M	56.3M	113.0M	306.0M	141.0M	87.1M	153.0M	160.0M	10.9M	3.6M	3.9M	4.6M	3.5M	8.0M
Other Income	339.0M	278.0M	237.0M	216.0M	325.0M	209.0M	158.0M	91.5M	--	--	--	--	--	--	--	--	--	--
Income Before Tax	4.3B	3.6B	2.1B	1.2B	955.0M	1.3B	1.3B	1.1B	716.0M	681.0M	1.1B	1.3B	1.3B	1.1B	775.0M	522.0M	352.0M	256.0M
Income Tax	923.0M	934.0M	364.0M	309.0M	164.0M	235.0M	65.9M	330.0M	92.1M	139.0M	164.0M	191.0M	175.0M	157.0M	113.0M	87.7M	40.5M	40.7M
+Net Income	3.4B	2.6B	1.7B	868.0M	791.0M	1.0B	1.3B	811.0M	624.0M	542.0M	985.0M	1.1B	1.1B	961.0M	662.0M	434.0M	311.0M	215.0M
Net Margin %	15.4%	12.3%	9.0%	5.0%	4.8%	5.8%	7.7%	7.1%	7.3%	7.0%	12.3%	16.0%	18.6%	18.7%	16.4%	13.4%	11.9%	10.6%
Net Income Attributable	2.9B	2.5B	1.7B	1.1B	829.0M	938.0M	1.2B	749.0M	585.0M	645.0M	1.0B	1.1B	1.1B	966.0M	661.0M	428.0M	310.0M	216.0M
Minority Interest	426.0M	191.0M	-1.1M	-234.0M	-37.9M	83.7M	54.5M	62.5M	39.7M	-103.0M	-17.2M	12.0M	6.1M	-5.1M	458,100	6.3M	1.1M	-802,500
Eps Basic	1.86	1.69	1.22	0.78	0.58	0.66	0.85	0.52	0.41	0.45	0.70	1.50	2.27	2.01	1.54	2.38	1.75	1.28
Eps Diluted	1.86	1.59	1.15	0.78	0.58	0.66	0.85	0.52	0.41	0.45	0.70	1.50	2.27	2.01	--	--	--	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash And Equivalents	4.0B	4.7B	4.7B	2.9B	2.8B	2.3B	1.8B	1.2B	1.2B	1.9B	2.0B	2.3B	2.4B	2.1B	4.2B	517.0M	341.0M	103.0M
Trading Financial Assets	1.9B	1.7B	448.0M	360.0M	265.0M	--	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	4.8B	4.7B	5.7B	5.3B	5.7B	6.5B	5.7B	4.9B	3.6B	2.7B	2.6B	2.2B	1.6B	1.3B	924.0M	615.0M	476.0M	379.0M
Notes Receivable	--	--	--	--	--	--	1.0B	1.5B	665.0M	1.1B	980.0M	1.0B	1.0B	936.0M	628.0M	493.0M	365.0M	103.0M
Notes And Accounts Receivable	4.8B	4.7B	5.7B	5.3B	5.7B	6.5B	6.7B	6.3B	4.2B	3.8B	3.6B	3.2B	2.6B	2.3B	1.6B	1.1B	841.0M	483.0M
Prepayments	383.0M	386.0M	432.0M	411.0M	391.0M	412.0M	500.0M	429.0M	277.0M	212.0M	261.0M	252.0M	610.0M	102.0M	101.0M	48.0M	34.5M	26.0M
Inventory	3.8B	3.8B	3.2B	3.4B	3.5B	3.4B	3.0B	2.5B	2.1B	2.2B	2.1B	1.8B	1.3B	1.1B	827.0M	595.0M	577.0M	479.0M
Total Current Assets	17.9B	18.3B	16.6B	14.0B	14.7B	14.2B	12.6B	11.6B	8.7B	9.2B	8.7B	8.2B	7.3B	5.7B	6.8B	2.3B	1.8B	1.1B
Long Term Equity Investment	4.2B	4.0B	3.8B	3.4B	2.8B	2.8B	2.3B	2.1B	31.9M	49.5M	47.2M	30.5M	28.5M	9.7M	--	--	--	--
Fixed Assets	--	9.8B	10.1B	10.7B	11.1B	11.3B	11.3B	11.1B	9.6B	6.0B	6.0B	5.1B	2.1B	1.5B	1.0B	746.0M	646.0M	471.0M
Fixed Assets Total	11.2B	9.8B	10.1B	10.7B	11.1B	11.3B	11.3B	11.1B	9.6B	6.0B	6.0B	5.1B	2.1B	1.5B	1.0B	746.0M	646.0M	471.0M
Construction In Progress	--	2.0B	1.1B	923.0M	840.0M	778.0M	820.0M	1.1B	2.1B	5.3B	4.3B	2.9B	3.7B	1.6B	417.0M	137.0M	48.3M	77.9M
Construction In Progress Total	1.2B	2.0B	1.1B	923.0M	841.0M	782.0M	823.0M	1.1B	2.1B	5.3B	4.4B	2.9B	3.8B	1.6B	420.0M	203.0M	104.0M	111.0M
Intangible Assets	1.2B	1.3B	1.2B	1.1B	988.0M	942.0M	921.0M	1.0B	1.0B	1.0B	980.0M	1.0B	988.0M	893.0M	340.0M	80.2M	79.9M	78.2M
Long Term Deferred Expenses	76.7M	56.0M	76.0M	46.9M	46.5M	17.2M	27.6M	13.5M	11.4M	10.4M	14.9M	23.9M	22.6M	18.0M	5.1M	1.1M	1.4M	2.1M
Total Non Current Assets	19.4B	18.2B	17.6B	17.5B	17.3B	17.3B	16.7B	16.4B	14.7B	13.4B	12.5B	9.8B	7.6B	4.8B	2.1B	1.0B	846.0M	682.0M
Total Assets	37.3B	36.5B	34.2B	31.5B	32.0B	31.5B	29.4B	28.0B	23.4B	22.6B	21.2B	17.9B	14.9B	10.5B	8.8B	3.3B	2.7B	1.8B
Short Term Borrowings	2.5B	3.5B	3.3B	3.4B	4.3B	3.2B	2.7B	2.7B	2.8B	2.2B	2.0B	1.1B	503.0M	940.0M	944.0M	1.1B	814.0M	416.0M
Accounts Payable	2.4B	2.2B	2.0B	1.8B	1.6B	1.7B	1.5B	1.4B	1.4B	1.5B	1.6B	1.3B	823.0M	578.0M	421.0M	323.0M	369.0M	383.0M
Advance Receipts	--	--	--	--	--	169.0M	235.0M	210.0M	58.8M	30.5M	24.8M	20.2M	12.7M	2.0M	109,500	2.6M	2.2M	604,400
Contract Liabilities	540.0M	715.0M	360.0M	265.0M	188.0M	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	9.1B	10.0B	12.1B	13.4B	12.3B	14.8B	10.4B	11.9B	10.2B	7.7B	5.7B	3.3B	2.4B	2.2B	1.6B	1.7B	1.4B	1.0B
Long Term Borrowings	342.0M	1.1B	2.0B	3.5B	3.2B	802.0M	870.0M	208.0M	290.0M	327.0M	850.0M	50.0M	1.7M	33.7M	140.0M	90.0M	10.0M	36.0M
Total Non Current Liabilities	1.4B	3.4B	5.2B	4.0B	5.7B	2.8B	6.0B	4.1B	1.7B	3.7B	4.6B	4.6B	3.5B	364.0M	193.0M	95.4M	18.8M	47.5M
Total Liabilities	10.6B	13.4B	17.3B	17.4B	18.0B	17.6B	16.4B	16.0B	11.9B	11.4B	10.2B	7.9B	5.9B	2.5B	1.8B	1.8B	1.5B	1.1B
Paid In Capital	1.6B	1.5B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	720.0M	480.0M	480.0M	480.0M	240.0M	180.0M	180.0M	75.0M
Capital Reserve	7.7B	6.1B	3.7B	3.6B	3.9B	3.5B	3.5B	3.5B	3.5B	3.7B	4.4B	4.6B	4.6B	4.7B	4.9B	192.0M	225.0M	142.0M
Surplus Reserve	1.6B	1.4B	1.2B	1.1B	921.0M	829.0M	705.0M	631.0M	590.0M	494.0M	441.0M	364.0M	300.0M	212.0M	142.0M	95.6M	68.3M	46.9M
Retained Earnings	11.6B	10.6B	9.2B	8.3B	7.8B	7.6B	7.1B	6.3B	5.8B	5.5B	5.1B	4.3B	3.4B	2.5B	1.7B	1.1B	700.0M	411.0M
Minority Equity	4.3B	3.3B	1.1B	273.0M	504.0M	718.0M	201.0M	179.0M	136.0M	104.0M	231.0M	264.0M	261.0M	94.0M	60.9M	11.3M	16.9M	16.1M
Equity Attributable	22.5B	19.7B	15.7B	13.9B	13.5B	13.2B	12.8B	11.8B	11.3B	11.1B	10.7B	9.8B	8.8B	7.8B	7.0B	1.6B	1.2B	675.0M
Total Equity	26.7B	23.0B	16.9B	14.1B	14.0B	13.9B	13.0B	12.0B	11.5B	11.2B	11.0B	10.0B	9.1B	7.9B	7.1B	1.6B	1.2B	691.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007
Cash From Sales	25.3B	26.4B	21.5B	21.2B	19.4B	19.9B	19.5B	12.1B	9.5B	8.8B	8.9B	7.4B	6.5B	5.1B	4.0B	3.2B	2.7B	2.2B
Tax Refunds Received	115.0M	153.0M	138.0M	--	--	--	64.8M	--	--	--	--	--	--	--	--	--	--	--
Total Operating Cash Inflow	25.8B	27.1B	22.0B	21.5B	19.8B	20.2B	19.9B	12.4B	9.7B	9.0B	9.0B	7.9B	6.7B	5.3B	4.1B	3.3B	2.7B	2.2B
Cash Paid For Goods	12.4B	13.7B	12.1B	12.2B	12.7B	13.3B	12.6B	7.9B	5.1B	5.1B	5.3B	4.8B	4.4B	3.5B	2.9B	2.2B	1.8B	1.5B
Cash Paid To Employees	3.5B	3.2B	2.6B	2.6B	2.1B	1.9B	1.6B	1.3B	1.3B	1.2B	1.2B	979.0M	755.0M	556.0M	413.0M	316.0M	236.0M	178.0M
Taxes Paid	2.9B	2.7B	2.2B	1.9B	1.5B	1.7B	1.8B	1.3B	1.0B	1.0B	961.0M	854.0M	788.0M	560.0M	380.0M	327.0M	253.0M	179.0M
Total Operating Cash Outflow	21.3B	21.7B	18.9B	18.6B	17.5B	18.0B	16.9B	11.2B	7.9B	7.8B	7.8B	6.8B	6.3B	5.0B	4.0B	3.0B	2.5B	2.0B
Operating Cash Flow	4.5B	5.3B	3.1B	2.8B	2.2B	2.2B	3.0B	1.2B	1.7B	1.2B	1.2B	1.1B	403.0M	343.0M	149.0M	251.0M	221.0M	168.0M
Total Investing Cash Inflow	11.3B	6.0B	5.1B	1.2B	2.1B	1.8B	1.7B	1.2B	954.0M	571.0M	98.1M	161.0M	43.8M	2.5M	2.2M	1.2M	3.7M	2.5M
Total Investing Cash Outflow	13.1B	9.4B	6.0B	2.7B	3.0B	3.2B	2.7B	3.6B	2.7B	2.7B	3.1B	2.3B	2.8B	2.6B	960.0M	320.0M	238.0M	175.0M
Investing Cash Flow	-1.8B	-3.4B	-857.0M	-1.5B	-905.0M	-1.4B	-959.0M	-2.4B	-1.8B	-2.1B	-3.0B	-2.1B	-2.8B	-2.6B	-958.0M	-319.0M	-234.0M	-173.0M
Cash From Borrowings	4.9B	4.0B	10.4B	9.0B	11.6B	5.8B	4.0B	2.8B	3.4B	3.4B	2.9B	2.1B	1.0B	995.0M	969.0M	1.0B	534.0M	431.0M
Dividends And Interest Paid	2.0B	1.2B	1.1B	1.1B	1.3B	912.0M	1.0B	675.0M	736.0M	636.0M	516.0M	410.0M	222.0M	216.0M	56.0M	51.0M	51.1M	29.3M
Debt Repayments	6.6B	7.3B	10.6B	9.4B	11.0B	5.3B	10.9B	8.7B	5.5B	3.0B	1.5B	2.1B	2.0B	1.1B	1.2B	716.0M	422.0M	391.0M
Total Financing Cash Inflow	5.6B	6.7B	11.7B	9.8B	11.9B	6.5B	11.0B	11.0B	6.1B	5.5B	3.6B	3.5B	4.8B	1.5B	6.0B	1.0B	734.0M	461.0M
Total Financing Cash Outflow	8.9B	8.7B	12.1B	11.0B	12.6B	7.0B	12.3B	9.8B	6.7B	4.5B	2.5B	2.6B	2.2B	1.3B	1.3B	835.0M	589.0M	439.0M
Financing Cash Flow	-3.3B	-2.1B	-407.0M	-1.3B	-722.0M	-468.0M	-1.4B	1.2B	-610.0M	1.1B	1.1B	947.0M	2.6B	170.0M	4.6B	189.0M	146.0M	21.7M
Net Change In Cash	-644.0M	-86.8M	1.9B	38.3M	564.0M	392.0M	612.0M	29.7M	-669.0M	232.0M	-641.0M	-108.0M	288.0M	-2.1B	3.8B	120.0M	132.0M	17.6M
Ending Cash Balance	3.9B	4.6B	4.7B	2.8B	2.8B	2.2B	1.8B	1.2B	1.2B	1.8B	1.6B	2.2B	2.4B	2.1B	4.2B	336.0M	216.0M	83.5M
Capex	1.7B	1.8B	897.0M	991.0M	1.2B	1.3B	1.3B	1.6B	1.4B	1.8B	2.8B	2.3B	2.8B	2.0B	647.0M	275.0M	227.0M	175.0M